Gastric cancer (GC) remains a major global health burden with unsatisfactory overall prognosis, largely attributed to profound heterogeneity, late-stage diagnosis, and therapeutic resistance. Over the past decade, immune checkpoint inhibitors (ICIs) targeting ... ...

请注册登录后继续浏览